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. Boettcher and D. J. Kay ing serum was dialysed against 3 ml of the same non-agglutinating serum. Dialysis was allowed to proceed for 7 days in the cold. After dialysis, the sperm¬ agglutinating activity of all solutions was investigated (Table 1 ) . A sample of the spermagglutinating serum which had lost its activity during dialysis was mixed with an equal volume of the phosphate-buffered saline which had been dialysed against the spermagglutinating serum. The spermagglutinating activity of the resulting solution was tested (Table 1 ) . the membrane was freeze-dried, taken up in 10 ml of distilled water and 5 ml of the solution made from the filtrate was mixed with 1 ml of human non-aggluti¬ nating serum. This mixture was allowed to stand in the cold for 1 hr, dialysed overnight against phosphate-buffered saline and subsequently reduced to a volume of 1 ml by pressure dialysis in a collodion membrane, surrounded by phosphate-buffered saline. The other 5 ml of filtrate was reduced to 1 ml by pressure dialysis in a similar manner.
The spermagglutinating activities of Rom serum, the serum after ultrafiltra¬ tion, the filtrate, and the filtrate added to a non-agglutinating serum, were determined ( Table 2 ). The anti-B haemagglutinating activity of Rom serum before and after ultrafiltration was 1/64.
It can be seen from Table 2 that the non-agglutinating serum acquired spermagglutinating activity when an extract of the filtrate from the sperm¬ agglutinating serum was added to it, though the filtrate extract itself was 110 . Boettcher and D. J. Kay inactive. Since the membrane used will allow only molecules with a mol. wt of less than 30,000 to pass, it appears that the compound which has been able to cause the non-agglutinating serum to become spermagglutinating has such a mol. wt. There is no suggestion that immunoglobulins were able to pass through the membrane since none could be detected by immunodiffusion or immunoelectrophoresis. Further, there was no loss of haemagglutinating activity.
During fractionation on Sephadex G-200, the spermagglutinating activity of Rom serum was found in association with the first, macro-molecular, peak (Boettcher & Kay, 1969; Boettcher et al., 1970) . The present evidence suggests, however, that the activity is associated with a molecule small enough to pass through a dialysis membrane. The molecule is presumably not active by itself, since saline dialysed against Rom serum is not spermagglutinating. Thus, the spermagglutination appears to involve a compound of low molecular weight, which will pass through a dialysis membrane, and combine with a high molecular weight non-dialysable compound in the serum. Either compound, by itself, is inactive.
Since the results of fractionation of Rom serum by Sephadex G-200 gel filtration, DEAE cellulose chromatography and zone electrophoresis exactly parallel the results for another spermagglutinating serum with non-immunoglobulin agglutinins (Boettcher & Kay, 1969) , and because of the results presented here, it is considered that the agglutinins in Rom serum are not immunoglobulins. It has been suggested that they are steroids attached to a ß-lipoprotein carrier (Boettcher & Kay, 1969) . However, ultracentrifugai preparation of jS-lipoproteins in a sodium bromide solution of density 1-20 g/ml, using the method of Schultz, Shreffler & Harvie (1968) 
